Amneal Pharmaceuticals Inc - Class A (AMRX) Company Profile & Statistics

Amneal Pharmaceuticals Inc - Class A
AMRX
(Nasdaq - US)
Closed
8.48
-0.52 (-5.83%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Pre Market:0+0.00 (0.00%)
Open
8.92
High
8.97
Low
8.38

About Amneal Pharmaceuticals Inc - Class A

CEO

Chirag Patel

Headquarters

400 crossing boulevard

bridgewater, nj 08807, united states

Auditor

Ernst & Young LLP

Employees

7,700

Share Holders

170

Website

www.amneal.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories Inc., is based in New Jersey, United States.

Amneal Pharmaceuticals Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	2.62B
Enterprise Value	5.19B
Enterprise Value/EBITDA (ttm)	12.81
Price to Earnings Ratio (ttm)	15.69
Price to Book (mrq)	N/A
Price to Sales (ttm)	0.98
Price to Cash (ytd)	6.27

Profitability

Gross Margin (ttm)	35.00%
Operating Margin (ttm)	6.29%
Profit Margin (ttm)	-6.87%
Return on Equity (ttm)	-346.26%
Return on Invested Capital (ttm)	-5.57%
Return on Assets (ttm)	4.85%

Income Statement

Revenue (ttm)	2.60B
Revenue Per Share (ttm)	8.39
Gross Profit (ttm)	910.37M
EBITDA (ttm)³	404.68M
Net Income Avi to Common (ttm)	-174.62M
Diluted EPS (ttm)	-0.68

Share Statistics

Beta (5Y Monthly)	1.17
52-Week Change	88.75%
S&P500 52-Week Change	29.10%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	309.54M
Dividend Yield	0.00%
Float ⁴	227.33M
% Held by Insiders	26.56%
% Held by Institutions	31.82%

Balance Sheet

Total Cash (mrq)	49.62M
Total Cash Per Share (mrq)	0.16
Total Debt (mrq)	2.61B
Total Debt/Equity (mrq)	-4545.39%
Current Ratio (mrq)	1.33%
Quick Ratio (mrq)	0.84%
Book Value Per Share (mrq)	-0.19

Cash Flow

Operating Cash Flow Per Share (ytd)	0.11
Free Cash Flow (ytd)	14.48M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Amneal Pharmaceuticals Inc - Class A

Trade With A Regulated Broker